Waldencast plc (NASDAQ:WALD – Get Free Report)’s stock price traded down 3.9% during mid-day trading on Thursday . The stock traded as low as $5.39 and last traded at $5.39. 498 shares changed hands during trading, a decline of 99% from the average session volume of 67,966 shares. The stock had previously closed at $5.61.
Analyst Upgrades and Downgrades
Separately, Telsey Advisory Group dropped their target price on Waldencast from $12.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 22nd.
Get Our Latest Analysis on WALD
Waldencast Stock Performance
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the business. Legal & General Group Plc purchased a new stake in shares of Waldencast in the third quarter valued at approximately $28,000. Amalgamated Bank boosted its holdings in shares of Waldencast by 68.1% in the third quarter. Amalgamated Bank now owns 3,277 shares of the company’s stock valued at $31,000 after purchasing an additional 1,328 shares during the period. UBS Group AG boosted its holdings in shares of Waldencast by 295.8% in the first quarter. UBS Group AG now owns 3,297 shares of the company’s stock valued at $33,000 after purchasing an additional 2,464 shares during the period. Barclays PLC boosted its holdings in shares of Waldencast by 440.0% in the second quarter. Barclays PLC now owns 4,093 shares of the company’s stock valued at $31,000 after purchasing an additional 3,335 shares during the period. Finally, Penserra Capital Management LLC purchased a new stake in shares of Waldencast in the first quarter valued at approximately $43,000. Hedge funds and other institutional investors own 41.97% of the company’s stock.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Recommended Stories
- Five stocks we like better than Waldencast
- The 3 Best Blue-Chip Stocks to Buy Now
- Comprehensive Analysis of PayPal Stock
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Compound Interest and Why It Matters When Investing
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.